Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...41424344454647484950...
CompanyDrug NameStatusIndication Group
Altana Daxas Submitted for approval in EURespiratory system
Pfizer Daxas Submitted for approval in EURespiratory system
Altana Daxas in Phase IIIRespiratory system
Pro-Pharmaceuticals DAVANAT and 5-Fluorouracil in Phase IIAntineoplastic & immunomodulating agents
aaiPharma Darvocet A500 Approved in USANervous system
Johnson & Johnson dapoxetine accomplished Phase IIIGenito urinary system & sex hormones
MGI PHARMA Dacogen Approved in USA, submitted for approval in EUAntineoplastic & immunomodulating agents
SuperGen Dacogen Approved in USA, submitted for approval in EUAntineoplastic & immunomodulating agents
ConjuChem DACGLP-1 accomplished Phase IIAlimentary tract & metabolism
ConjuChem DAC:GRF accomplished Phase ISystemic hormonal preparations
Lilly Cymbalta Approved in USANervous system
Lilly Cymbalta Approved in EU and USANervous system
AJI Pharma USA Curdlan in Phase IIAnti-infectives for systemic use
Chiron Cubicin Approved in EU and USAAnti-infectives for systemic use
AstraZeneca Crestor in Phase IIICardiovascular system
AstraZeneca Crestor in Phase IIICardiovascular system
AstraZeneca Crestor Approved in USA and EUAlimentary tract & metabolism
Solvay CREON Submitted for approval in JapanAlimentary tract & metabolism
Peregrine Cotara accomplished Phase IAntineoplastic & immunomodulating agents
Peregrine Cotara accomplished Phase IAntineoplastic & immunomodulating agents
...41424344454647484950...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.